Product image
Product image thumbnail
Product image thumbnail
Product image thumbnail
Product image thumbnail
Product image thumbnail
Product image thumbnail
Product image thumbnail
Product image thumbnail
Product image thumbnail
Product image thumbnail
Product image thumbnail

卓營方 Supra NMN

$1,288.00


  • 逆轉年輕
  • 刺激細胞重生丶修復受損細胞
  • 回復機能

加到收藏清單 Go to Wishlist
SKU: HN007 類別: 分享:

商品說明

卓營方Supra NMN

 

卓營方Supra NMN配方蘊含NMN(煙酰胺單核苷酸)及天然的雨生紅球藻精華兩大星級成分,適合關注延緩衰老、體能、皮膚、眼睛、肝臟、腦部、心臟及心血管健康的人士服用。

 

卓營方Supra NMN的蝦青素是萃取自天然的雨生紅球藻。雨生紅球藻的蝦青素含量是磷蝦油10倍以上。[3-6]科學證明蝦青素有強效抗氧化和護肝功能,營養價值很高。[1,9,22] 蝦青素具有獨特的分子結構,讓它能有非凡效益的化學特質,有著比其他類胡蘿蔔素如葉黃素、β-胡蘿蔔素等不少於十倍或更高的抗氧化功效。[1,7,8,10] 同時能阻止細胞膜氧化,終止自由基連鎖反應。[1,7,10,16] 蝦青素能穿越血腦屏障進入視網膜組織,為視網膜提供防護,減低紫外線造成的傷害,同時加速復原,為紓緩眼部不適非常有幫助。[17-19]攝取足夠的抗氧化劑對男女老少的健康均為重要,能提升老年時整體健康,並有效保持良好認知能力及長壽。[14]

 

卓營方Supra NMN更添加煙酰胺單核苷酸(NMN)是NAD+的生物合成前體,已知可促進細胞NAD+的產生並抵消與組織NAD +水平下降有關的與年齡相關的病理。[30]

科研實證NMN(煙酰胺單核苷酸),有效地活化細胞機能,延緩衰老,亦能加強身體修復能力。[28,29,32]有研究表示隨著年齡增長,體內煙酰胺腺嘌呤二核苷酸磷酸(NAD+)生成機制會變差及以至人體內NAD+水平變低,導致衰老。研究發發現有特別運輸通道(Slc12a8) 能將NMN直接運送到細胞內供體內生成NAD+,以維持NAD+在理想水平,從而緩慢早衰綜合徵狀和正常衰老。[30-32]

 

NMN(煙酰胺單核苷酸) 對器官的好處

去乙醯酶(Sirtuins)基因涉及衰老與細胞凋亡的過程。研究顯示NMN(煙酰胺單核苷酸)激活去乙醯酶基因製造其蛋白刺激細胞的修補工作,特別是對那些不會更新的組織,像是心臟、眼及腦,減緩細胞死亡的過程,隨後衰老所致疾病可望一邊促進細胞的維修機制,一邊得到抑制和恢復。[32,34]

 

對眼部的好處

卓營方Supra  NMN內含豐富NMN(煙酰胺單核苷酸) 、蝦青素、葉黃素、胡蘿蔔素和角黃素的天然類胡蘿蔔素,是不能被人體自行合成, 所以必須由食物或補充劑中攝取。[1-2] 葉黃素是天然類胡蘿蔔素,是構成視網膜黃斑點及視網膜其他部分的成份。[11] 光線中的藍波段是最能損壞眼睛及皮膚的光譜,葉黃素可過濾藍波段光線,從而減低紫外線照射對眼睛和皮膚的傷害。[11-13]

 

NMN能維持免疫系統、眼部組織的健康及良好視力,有研究表明NAD +水平的急促下降會導致眼睛迅速發生神經變性和視力喪失,但科學家發現,補充這種分子可以預防不良反應並改善視力。 [15,33-35] 有研究更表示NMN 把去乙醯酶(Sirtuins)基因激活後會生產去乙酰化酶-細胞保護酶(SIRT1-7)具有抗衰老及緩減細胞凋亡能力,而增加了細胞保護酶SIRT1的水平,令視網膜細胞內的氧化應激減少,減少炎症產生,減少對視網膜的傷害。[35]

 

卓營方Supra NMN的功效:

  • 強力抗氧化 [1,9,17,28]
  • 增強免疫系統防護 [1,17]
  • 保護人體細胞不受紫外線和自由基的傷害 [1,7,13-17,20,31]
  • 促進身體健康增強體質 [1,17,28]
  • 促進皮膚健康和延緩衰老 [7,17,20-21,28,31]
  • 促進心臟及心血管健康 [1,7,17,23-24,29,32]
  • 促進肝臟健康 [2,7,17,32]
  • 有助提升能量,令人更精神 [24-25,28]
  • 有助肌肉運動後迅速復原,緩解運動後疲勞 [7,26]
  • 有助維持眼睛健康,延緩視力老化 [7,15-18,27,32-35]

 

建議服用份量:

成人每天建議餐後服用2粒或遵照醫生指示。

 

注意:孕婦或哺乳期婦女,服用本產品前請先諮詢家庭醫生意見。

 

參考文獻:

References:
1. Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: Sources, Extraction, Stability, Biological Activities and Its Commercial Applications–A Review. Mar Drugs. 2014;12(1):128-52. doi: 10.3390/md12010128.
2. Kistler A, Liechti H, Pichard L, Wolz E, Oesterhelt G et al. Metabolism and CYP-inducer properties of astaxanthin in man and primary human hepatocytes. Arch Toxicol. 2002;75(11-12):665-75.
3. Lorenz RT, Cysewski GR. Commercial potential for Haematococcous microalgae as a natural source of Astaxanthin. Trends Biotechnol. 2000;18(4):160-7.
4. Kwantes JM, Grundmann O. A brief review of krill oil history, research, and the commercial market. J. Diet Suppl. 2004 Apr 1.
5. Krill – Marine Lipid Complex Technical Data Sheet. NutriScience Innovations: Product Information. Available online at http://www.nutriscienceusa.com/KrillOilMLC.htm
6. Fish oil vs. krill oil. Omega-Research. Available online at http://www.omega-research.com/
7. Yuan JP, Peng J, Yin K, Wang JH. Potential health-promoting effects of Astaxanthin: A high-value carotenoid mostly from microalgae. Mol Nutr Food Res. 2011;55(1):150-65.
8. Spiller GA, Dewell A. Safety of an Astaxanthin-Rich Haematococcus pluvialis Algal Extract: A Randomized Clinical Trial. J Med Food. 2003 Spring;6(1):51-6.
9. Astaxanthin. Martindale: The Complete Drug Reference. Available online at: http://www.medicinescomplete.com
10. Kidd P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern Med Rev. 2011;16(4):355-64.
11. Kijlstra A, Tian Y, Kelly ER, Berendschot TT. Lutein: More than just a filter for blue light. Prog Retin Eye Res. 2012;31(4):303-15.
12. Ozawa Y, Sasaki M, Takahashi N, Kamoshita M, Miyake S, Tsubota K. Neuroprotective effects of lutein in the retina. Curr Pharm Des. 2012; 18(1):51-6.
13. Carpenter KL, van der Veen C, Hird R, Dennis IF, Ding T, Mitchinson MJ. The carotenoids beta-carotene, canthaxanthin and zeaxanthin inhibit macrophage-mediated LDLoxidation. FEBS Lett. 1997;401(2-3):262-6.
14. Barros MP, Poppe SC, Bondan EF. Neuroprotective properties of the marine carotenoid astaxanthin and omega-3 Fatty acids, and perspectives for the natural combination of both in krill oil. Nutrients. 2014;6(3):1293-317.
15. Lin JB, Kubota S, Ban N, Yoshida M, Santeford A, Sene A, Nakamura R, Zapata N, Kubota M, Tsubota K, Yoshino J, Imai SI, Apte RS. NAMPT-Mediated NAD(+) Biosynthesis Is Essential for Vision In Mice. Cell Rep. 2016 Sep 27;17(1):69-85. doi: 10.1016/j.celrep.2016.08.073. PMID: 27681422; PMCID: PMC5104206.
16. Lennikov A, Kitaichi N, Fukase R, Murata M, Noda K et al. Amelioration of ultraviolet-induced photokeratitis in mice treated with Astaxanthin eye drops. Mol Vis. 2012;18:455-64.
17. Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol. 2003;21(5):210-6.
18. Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N et al. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci. 2003;44(6):2694-701.
19. Suzuki Y, Ohgami K, Shiratori K, Jin XH, Ilieva I et al. Suppressive effects of astaxanthin against rat endotoxin induced uveitis by inhibiting the NF-kB signaling pathway. Exp Eye Res. 2006;82(2):275-81.
20. Hama S, Takahashi K, Inai Y, Shiota K, Sakamoto R et al. Protective effects of topical application of a poorly soluble antioxidant astaxanthin liposomal formulation on ultraviolet-induced skin damage. J Pharm Sci. 2012;101(8):2909-16.
21. Santos SD, Cahú TB, Firmino GO, de Castro CC, Carvalho LB Jr et al. Shrimp waste extract and astaxanthin: Rat alveolar macrophage, oxidative stress and inflammation. J Food Sci. 2012;77(7):H141-6.
22. Fassett RG, Coombes JS. Astaxanthin: A potential therapeutic agent in cardiovascular disease. Mar Drugs. 2011;9(3):447-65.
23. Fassett RG, Coombes JS. Astaxanthin in cardiovascular health and disease. Molecules. 2012;17(2):2030-48.
24. Song XD, Zhang JJ, Wang MR, Liu WB, Gu XB, Lv CJ. Astaxanthin induces mitochondria-mediated apoptosis in rat hepatocellular carcinoma CBRH-7919 cells. Biol Pharm Bull. 2011;34(6):839-44.
25. Wolf AM, Asoh S, Hiranuma H, Ohsawa I, Iio K et al. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J Nutr Biochem. 2010;21(5):381-9.
26. Djordjevic B, Baralic I, Kotur-Stevuljevic J, Stefanovic A, Ivanisevic J et al. Effect of astaxanthin supplementation on muscle damage and oxidative stress markers in elite young players. J Sports Med Phys Fitness. 2012;52(4):382-92.
27. Cort A, Ozturk N, Akpinar D, Unal M, Yucel G et al. Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure. Regul Toxicol Pharmacol. 2010;58(1):121-30.
28. Yoshino J, Baur JA, Imai SI. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018 Mar 6;27(3):513-528. doi: 10.1016/j.cmet.2017.11.002. Epub 2017 Dec 14. PMID: 29249689; PMCID: PMC5842119.
29. Kiss T, Balasubramanian P, Valcarcel-Ares MN, Tarantini S, Yabluchanskiy A, Csipo T, Lipecz A, Reglodi D, Zhang XA, Bari F, Farkas E, Csiszar A, Ungvari Z. Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment. Geroscience. 2019 Oct;41(5):619-630. doi: 10.1007/s11357-019-00074-2. Epub 2019 May 29. PMID: 31144244; PMCID: PMC6885080.
30. Grozio A, Mills KF, Yoshino J, Bruzzone S, Sociali G, Tokizane K, Lei HC, Cunningham R, Sasaki Y, Migaud ME, Imai SI. Slc12a8 is a nicotinamide mononucleotide transporter. Nat Metab. 2019 Jan;1(1):47-57. doi: 10.1038/s42255-018-0009-4. Epub 2019 Jan 7. Erratum in: Nat Metab. 2019 Jul;1(7):743. PMID: 31131364; PMCID: PMC6530925.
31. Kincaid JW, Berger NA. NAD metabolism in aging and cancer. Experimental Biology and Medicine. 2020;245(17):1594-1614. doi:10.1177/1535370220929287
32. Kane, A. and D. Sinclair. Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases. Circulation Research .2018(123): 868–885.
33. Ebeling, Mara & Polanco, Jorge & Qu, Jun & Tu, Chengjian & Montezuma, Sandra & Ferrington, Deborah. (2020). Improving retinal mitochondrial function as a treatment for age-related macular degeneration. Redox Biology. 34. 101552. 10.1016/j.redox.2020.101552.\
34. Jadeja RN, Thounaojam MC, Bartoli M, Martin PM. Implications of NAD+ Metabolism in the Aging Retina and Retinal Degeneration. Oxid Med Cell Longev. 2020 May 9;2020:2692794. doi: 10.1155/2020/2692794. PMID: 32454935; PMCID: PMC7238357.
35. Chen X, Amorim JA, Moustafa GA, Lee JJ, Yu Z, Ishihara K, Iesato Y, Barbisan P, Ueta T, Togka KA, Lu L, Sinclair DA, Vavvas DG. Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment. Aging (Albany NY). 2020 Dec 29;12. doi: 10.18632/aging.202453. Epub ahead of print. PMID: 33373320.

Disclaimer: This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese
Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.

 

免責聲明:此產品沒有根據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲稱亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。

 

Shopping cart

No products in the cart.